HomeTherapeutic areasImmunology › Graft-versus-Host Disease

Graft-versus-Host Disease (1 companies)

Companies with an active program in Graft-versus-Host Disease.

Ticker Company Therapeutic areas Programs Lead stage Programs
INKT MiNK Therapeutics ImmunologyOncology+1 Rare 1 Phase 2 7